To study the effect of Narikela Khanda and Kusmanda Khanda in Amlapitta w.s.r. to Gastro- Reflux Disease

A CLINICO-PATHOLOGICAL STUDY ON AMLAPITTA W.S.R TO GASTROESOPHAGEAL REFLUX DISEASE (GERD)AND ITS COMPARATIVE MANAGEMENT WITH NARIKELA KHANDA AND KUSMANDA KHANDA. - NKKKGR

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/05/033525

Enrollment

Registered

2021-05-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

Intervention1: Narikela Khanda: Narikela Khanda :- 6 gm twice daily after food with water for 30 days Control Intervention1: Kushmanda Khanda: Kushmanda Khanda:- 6 gm twice daily after food with water

Eligibility

Inclusion criteria

Inclusion criteria: 1. Both new and previous treated cases will be included. 2. Patients who fulfill the diagnostic criteria. 3. Patients age between 15-60 years. 4. Subject willing to follow the procedures as per the study protocol and signing informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patient with any grevious systemic illness, Malignancy, Genetic disorder, Tuberculosis, Hepatitis B or C, or HIV, Diaetis. 2. Patient having Parinamashoola or Annadravashoola, Cholelithiasis and Cholecystitis. 3. H/O haematemesis, malena, gastric surgery, CKD & CHD. 4. Patients below 15 years and above 60 years.. 5. Patients not willing to participate in the trial. 6. Pregnant and lactating females.

Design outcomes

Primary

Measure	Time frame
Decrease in symptoms- Avipaka, Klama, Utklesha, Tiktomlodgara, Gourava, Hridkanthadaha, AruchiTimepoint: Decrease in symptoms- Avipaka, Klama, Utklesha, Tiktomlodgara, Gourava, Hridkanthadaha, Aruchi	—

Secondary

Measure	Time frame
Narikela Khanda may be more effective than Kushmanda Khanda individuallyTimepoint: 31 days	—

Countries

India

Contacts

Public ContactProf Dr Pradip Kumar Panda

Govt. Ayurvedic College & Hospital, Balangir

drpkpandanidan@rediffmail.com9437150643

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026